Phase 2 Study of the Safety and Efficacy of JTM201 (Botulinum Toxin Type A) to Treat Moderate or Severe Glabellar Lines

Conditions: Glabellar Lines Interventions: Biological: JTM201; Biological: Placebo Sponsors: Jetema USA Inc. Not yet recruiting

Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials